GSK’s share price has fallen significantly in the past 12 months, but this could mean it looks a major bargain now, ...

The GSK (GSK.L) share price has fallen considerably since the company’s demerger with its consumer healthcare arm Haleon (HLN.L) in July 2022. However, the stock did surge around 7.5% at the end of ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2827.05. The stock has experienced fluctuations ...

That’s a really important movement. Coupled with the reduction of the Zantac risk, I believe this could be the catalyst for share price growth. GSK hasn’t been on my watchlist for a while ...

GlaxoSmithKline ( ($GSK) ) has shared an update. On May 7, 2025, GSK plc announced the purchase of 687,081 of its own ordinary shares at prices ...

GSK’s (LSE: GSK) share price is down 20% from its 15 May 12-month traded high of £18.19. This sort of a drop could indicate that a bargain-basement buying opportunity is to be had. Or it could flag ...

The AstraZeneca share price has pulled back in recent months. Dr James Fox explores how the stock compares with pharma peer GSK. The post Does the GSK or AstraZeneca share price currently offer the ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

In another note of news, a key aide to HHS Secretary Robert F. Kennedy Jr. said that popular GLP-1 weight loss drugs -- Novo Nordisk's ( NVO) Wegovy (semaglutide) and Eli Lilly's ( LLY) Zepbound ...